Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

NeoProgen, a US-based biotech spinout of University of Maryland, Baltimore, completed a $1.5m seed round on Wednesday backed by the institution’s Maryland Momentum Fund and tech transfer office UM Ventures, as well as University of Maryland, Baltimore and Tedco. NeoProgen is working on a stem cell-based therapy for patients suffering from a heart attack or…

The rest of this content is only accessible to Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.